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The EspF protein is secreted by the type III secretion system of enteropathogenic and enterohemorrhagic
Escherichia coli (EPEC and EHEC, respectively). EspF sequences differ between EHEC O157:H7, EHEC
O26:H11, and EPEC O127:H6 in terms of the number of SH3-binding polyproline-rich repeats and specific
residues in these regions, as well as residues in the amino domain involved in cellular localization. EspFO127
is important for the inhibition of phagocytosis by EPEC and also limits EPEC translocation through antigen-
sampling cells (M cells). EspFO127 has been shown to have effects on cellular organelle function and interacts
with several host proteins, including N-WASP and sorting nexin 9 (SNX9). In this study, we compared the
capacities of different espF alleles to inhibit (i) bacterial phagocytosis by macrophages, (ii) translocation
through an M-cell coculture system, and (iii) uptake by and translocation through cultured bovine epithelial
cells. The espF gene from E. coli serotype O157 (espFO157) allele was significantly less effective at inhibiting
phagocytosis and also had reduced capacity to inhibit E. coli translocation through a human-derived in vitro
M-cell coculture system in comparison to espFO127 and espFO26. In contrast, espFO157 was the most effective
allele at restricting bacterial uptake into and translocation through primary epithelial cells cultured from the
bovine terminal rectum, the predominant colonization site of EHEC O157 in cattle and a site containing M-like
cells. Although LUMIER binding assays demonstrated differences in the interactions of the EspF variants with
SNX9 and N-WASP, we propose that other, as-yet-uncharacterized interactions contribute to the host-based
variation in EspF activity demonstrated here.
Enterohemorrhagic Escherichia coli (EHEC) is an emerging
zoonotic pathogen, particularly in industrialized countries (6).
EHEC strains cause sporadic outbreaks of severe disease in
humans, the most important being hemorrhagic colitis (HC)
and hemolytic-uremic syndrome (HUS); the latter disease re-
sults in kidney damage and may lead to death (8, 28). Shiga
toxins (Stx) produced by EHEC strains are the main factors
responsible for these serious outcomes in humans. In contrast,
Enteropathogenic E. coli (EPEC) is another pathogenic type
of E. coli that can also cause severe intestinal disease in hu-
mans, although these infections are not usually associated with
HC and HUS since these strains do not produce Shiga toxins.
Unlike EHEC, there is no clear evidence that EPEC strains are
zoonotic, although strains do circulate and cause diseases in
animals (56).
Our understanding of EHEC pathogenesis is primarily
based on studies of the EHEC O157 and EHEC O26 sero-
groups that are associated with most human EHEC infections
in Europe, North America, and Japan (39, 40, 41). Both sero-
groups are considered to be present in ruminants, in particular
cattle as the primary reservoir (5, 41, 59, 60). Although there
are many EPEC serotypes, extensive research has been carried
out on the sequenced human EPEC O127 strain E2348/69.
EHEC and EPEC strains express a type III secretion system
(T3SS) that is important for colonization of the human or
animal host (33, 36, 56, 74). The T3SS injects effector proteins
into host cells that manipulate cellular processes to promote
the colonization and persistence of the bacterium in the
gastrointestinal tract (16, 19, 20, 34, 52, 64). The primary phe-
notype associated with the T3SS is intimate attachment be-
tween the bacterial outer membrane protein intimin and the
T3SS translocated intimin receptor (Tir) (42). In both EHEC
and EPEC, the genes encoding this protein secretion system
are expressed from the locus of enterocyte effacement (LEE)
pathogenicity island (33, 36). Although several effector pro-
teins are also expressed from the LEE, a number of additional
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secreted effector proteins have been identified that are ex-
pressed primarily from integrated phage elements scattered
throughout the O157 chromosome (79). EHEC and EPEC
strains have different combinations of effector proteins, po-
tentially reflecting host adaptation and differences in patho-
genesis.
EspF is a LEE-encoded effector protein that requires the
CesF chaperone to be translocated by the T3SS into host cells
(20). EspF has multiple proline-rich domains that act by bind-
ing to SH3 domains or enabled/VASP homology 1 (EVH1)
domains of host cell signaling proteins (15, 55). For example,
EPEC EspFO127 binds to sorting nexin 9 (SNX9) via its SH3
amino-terminal region (1, 51). EspF is involved in disrup-
tion of tight junctions and increases monolayer permeability
in part through the redistribution of occludins (54, 80). EspF
sequences differ between EPEC and EHEC strains, and the
EHEC O157 variant has a more modest impact on transepi-
thelial electrical resistance (TER) (80). EspF in combination
with other effectors inhibits the water transporter SGLT-1,
highlighting the importance of effector interplay (16, 43).
EPEC EspFO127 is targeted to mitochondria with the N-termi-
nal region of EspF functioning as an import signal. EPEC
EspFO127 causes an increase in mitochondrial membrane per-
meabilization in addition to the release of cytochrome c from
mitochondria into the cytoplasm and subsequent caspase-9 and
caspase-3 cleavage, leading to cell death (15, 58, 65, 66). More
recent work has demonstrated that EspF can lead to loss of
nucleolin from the nucleolus, an activity driven by EspF’s ac-
tivity on mitochondria (17). EPEC EspFO127 also plays an
important role in inhibition of bacterial uptake by macro-
phages (70), preventing macrophage phagocytosis via inhibi-
tion of the phosphatidylinositol 3-kinase (PI3K)-dependent
pathway of bacterial uptake (11, 70).
Intestinal epithelium is composed of multiple cell types,
including absorptive enterocytes, enteroendocrine, goblet, and
Paneth cells. These cells derive through asymmetrical division
migration and differentiation from pluripotent stem cells. An
additional specialized epithelial cell type, termed M cells (i.e.,
“membranous” or “microfold” cells), are associated particu-
larly with epithelium overlying gut-associated lymphoid tissue.
This is referred to as follicle-associated epithelium (FAE) and
is a site of active immunological function. In contrast to villous
epithelium, FAE contains no or fewer goblet cells (67), defen-
sin- and lysozyme-producing Paneth cells (26, 27) and ex-
presses low amounts of membrane-associated hydrolases (68).
The M cells generally lack the distinct microvilli and thick
filamentous brush border glycocalyx (24) and instead have
variable microfolds. Together, these features of M cells pro-
mote contact of antigens with gut epithelium and result in
sampling of antigens from the intestinal lumen and transfer to
antigen-presenting cells within an intraepithelial pocket (62)
on its basolateral side (21, 22, 35). EPEC EspFO127 has also
been shown to inhibit EPEC translocation across antigen-
transporting epithelial M cells in an in vitro model (53) based
on a published coculture system (44).
In cattle, the terminal rectum is rich in lymphoid FAE con-
taining M cells (49). Since this is the predominant site colo-
nized by EHEC O157 in cattle (60), we hypothesized that EspF
may have an important role in cattle colonization by inhibiting
translocation of the organism by M cells and that the sequence
differences of EspF in EHEC O157:H7 may reflect selection
for its function in the bovine host. To test this, we compared
the capacities of different espF alleles to inhibit phagocytosis
and limit bacterial translocation through M cells derived in a
coculture system to their capacities to inhibit bacterial uptake
into and translocation through cells cultured from the bovine
terminal rectum.
MATERIALS AND METHODS
Bacterial strains and media. EPEC, EHEC, and other E. coli strains used in
the present study are detailed in Table 1. Bacteria were cultured in Luria-Bertani
(LB) broth, minimal essential medium (MEM)-HEPES, or Dulbecco modified
Eagle medium (DMEM) with antibiotics included when required at the following
concentrations: chloramphenicol, 20 g/ml; kanamycin, 50 g/ml; and ampicillin,
100 g/ml.
Cloning of espF alleles. espF alleles were amplified from the different strains
using the primers defined in Table 2 and the products cloned into pTS1 (Table
3). BamHI and HindIII sites were used to clone the alleles from EHEC O157:H7
and O26:H11 strains. For EPEC O127 espF, since this contains a natural HindIII
site, an alternative cloning strategy was used: pMB102 (Table 3) was digested
with HindIII, followed by Klenow polymerase (Roche) treatment to create a
blunt end and then restriction with BamHI. The EPEC O127:H6 espF PCR
product was digested with BamHI and EcoRV and then cloned into the re-
stricted pTS1. Restriction digests were set up according to the manufacturer’s
instructions (New England Biolabs) with the recommended enzyme buffers. All
clones were checked by sequencing, and matched published database sequences
for the alleles giving the amino acid sequences are shown in Fig. 2. Gateway
cloning of the espF alleles from the different E. coli strains was also carried out
for the LUMIER assays. espF alleles were amplified by using a proofreading Taq
polymerase with the primers defined in Table 2 and cloned into the Gateway
vector pDONR-207 (Invitrogen) to form entry clones. The obtained clones were
checked for the correct insert by DNA plasmid extraction and restriction diges-
tion using BanII. Once in the Gateway system, clones were easily transferred to
the required destination vectors, including pTREX-DEST30 (protein A fusions)
and pRenilla (luciferase fusions).
To analyze type III secretion profiles and EspF secretion from the EPEC
TABLE 1. Bacterial strains used in this study
Strain Serotype Source
E. coli ZAP1139 O26:H11 Cattle isolate, Stx negative; Chris Low, Scottish Agricultural College, Penicuik, Scotland
E. coli TUV93-0 O157:H7 Stx phage-negative derivative of the sequenced human strain EDL933; John Leong,
Massachusetts Medical School, Boston, MA (10)
E. coli TUV93-0espF O157:H7 This study
S. enterica serovar (SL1344)
Typhimurium
Mark Jepson (38)
E. coli EPEC E2348/69 (espF) O127:H6 Derivative of human isolate supplied by Brendan Kenny, University of Newcastle,
Newcastle, United Kingdom (74)
E. coli AAEC 185 O148 Laboratory stock
E. coli DH5 Rough Laboratory stock
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O127:H6 espF and complemented strains, previous procedures were used
(50, 61, 71). EspD was detected by using a monoclonal antibody kindly
supplied by T. Chakraborty (Giessen, Germany). EspF was detected by using
polyclonal antibodies supplied from C. Sasakawa (Tokyo, Japan) (58), and G.
Hecht (University of Illinois at Chicago) (80).
Phagocytosis assays. The murine macrophage cell line (RAW 264.7) was
cultured in Dulbecco modified Eagle medium (DMEM; Sigma) supplemented
with 10% heat-inactivated fetal bovine serum (FBS; Sigma), 1 U of penicillin, 1
g of streptomycin/ml, and 2 mM L-glutamine (final concentrations). Cells were
grown at 37°C in 5% CO2 and moisture. The bacteria, transformed with pUC-gfp
(Table 3), were inoculated from LB broth overnight cultures into DMEM to an
optical density at 600 nm (OD600) of 0.3. When analyzed, the espF alleles were
induced with 1 mM IPTG (isopropyl--D-thiogalactopyranoside). At an OD600 of
0.7, the bacterial cultures were diluted 1:5 into prewarmed DMEM, and 300 l
was added to the macrophages (initially seeded at 105 cells/well the day before).
The cells were then incubated at 37°C in 5% CO2 in a moist box for the desired
incubation time. The cells were washed three times with sterile phosphate-
buffered saline (PBS) and fixed using 4% paraformaldehyde (PFA). After three
washes with PBS, the samples were incubated for 90 min with the relevant
anti-lipopolysaccharide (LPS) antibody (MAST Group, Ltd.) at 1:4,000 and,
after several washes, were incubated with Alexa Fluor 594-conjugated goat anti-
rabbit immunoglobulins antibody (1/1,000; Molecular Probes) for an hour. The
slides were then washed three times with PBS and mounted with Hydromount
(National Diagnostic), and coverslips were applied. All bacteria, internal and
external, express green fluorescent protein (GFP), whereas only the bacteria
external to the macrophages were stained with the anti-O157 LPS antibody. This
differential staining allows the proportion of internalized bacteria to be quanti-
fied.
Microscopy. Confocal data were acquired using a 1,024 by 1,024 pixel image
size, a Zeiss Plan Apochromat 1.4 NA 63 oil immersion lens, and a multitrack
(sequential scan) experimental setup on a Zeiss LSM510. Image data, acquired
at Nyquist sampling rates, were deconvolved using Huygens software (Scientific
Volume Imaging, Netherlands), the resulting three-dimensional models were
analyzed, and orthogonal views were created using NIH ImageJ software; the
final figures were assembled in Adobe Photoshop.
LUMIER assays. Proteins were transiently expressed in HEK293 cells as
hybrid proteins with the Staphylococcus aureus protein A tag or Renilla reniformis
luciferase fused to their amino termini. Portions (20 ng) of each expression
construct were transfected into HEK293 cells using 0.05 l of Lipofectamine
2000 (Invitrogen) in 96-well plates. After 40 h, the medium was removed, and the
cells were lysed on ice in 10 l of ice-cold lysis buffer (20 mM Tris [pH 7.5], 250
mM NaCl, 1% Triton X-100, 10 mM EDTA, 10 mM dithiothreitol [DTT],
protease inhibitor cocktail and phosphatase inhibitor cocktail [both from Roche],
and Benzonase [Novagen]). Sheep anti-rabbit IgG-coated magnetic beads were
also added (Dynabeads M280 [Invitrogen]; 2 mg/ml, final concentration), fol-
lowed by incubation on ice for 15 min. Then, 100 l of washing buffer (PBS, 1
mM DTT) was added per well, and 10% of the diluted lysate was removed to
determine the luciferase activity present in each sample before washing. The rest
of the sample was washed six times in washing buffer. Luciferase activity was
measured in the lysate as well as in washed beads. Negative controls (nc) were
wells transfected with the plasmid expressing the luciferase fusion protein and a
vector expressing a dimer of protein A. For each sample, four values were
measured: the luciferase present in 10% of the sample before washing (“input”),
the luciferase activity present on the beads after washing (“bound”), and the
same two values for the negative controls (i.e., “input nc” and “bound nc”).
Normalized signal-to-noise ratios were calculated as published previously (4, 9):
TABLE 2. Primers used in the study
Primer Sequence (5–3)a Use
EspF1F CAGGATCCTCACAATGCAACTTAATATCG Cloning of espFO26 into pTS1
EspF1R CTAAGCTTGATATAAAAAGGCATGAATTATGC
EspF2F CAGGATCCACCACACAATTTGATATCGGT Cloning of espFO157 into pTS1
EspF2R CTAAGCTTGATATAAAGAGGCATAAATTATGC
EspF3F CAGGATCCACCACGCAATTTGATATCGGT Cloning of espFO127 into pTS1
EspF3R CTGATATCGATATAAAGAGGCATAAATTATGC
EspF4F ATGCTTAATGGAATTAGTAACGC Gateway cloning of espFO157 and espFO127
EspF4R CTACCCTTTCTTCGATTGCTCATAG
EspF5F ATGCTTAATGGAATTAGTCAAGC Gateway cloning of espFO26
EspF5R CTACACAAACCGCATAG
a Restriction sites are underlined.
TABLE 3. Plasmids used in this study
Plasmid Description Source or reference
pMB102 Low-copy cloning vector with inducible lac promoter Tammari Schneiders,
University of
Belfast (69)
pAT1 pMB102 containing espFO127 This study
pAT2 pMB102 containing espFO157 This study
pAT3 pMB102 containing espFO26 This study
pUC-gfp pUC18 derivative containing gfp Laboratory stock
pAJR145 rpsM-GFP transcriptional fusion in pACYC184. Laboratory stock
pAJR146 rpsM-RFP transcriptional fusion in pACYC184 (pDW16) based
on the DsRed T3_S4T gene
71, 76
pDONR-207 Gateway entry cloning vector Invitrogen
pTREX-DEST30-prA Vector to generate amino-terminal protein A fusions for
LUMIER binding assays
4
pRenilla Vector to generate amino-terminal luciferase fusions for Lumier
binding assays
4
pAT4-6 espFO157, espFO26, and espFO127 cloned into pTREX-DEST30-
prA, respectively
This study
pAT7-9 espFO157, espFO26, and espFO127 cloned into pRenilla, respectively This study
pTREX-DEST30-SNX9 pRenilla-SNX9 Vectors expressing SNX9-protein A or -luciferase fusion proteins This study
pTREX-DEST30-N-WASP
pRenilla-N-WASP
Vectors expressing N-WASP–protein A or –luciferase fusion
proteins
This study
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(bound/input)/(bound nc/input nc). Z-scores were then calculated using these
normalized values by subtracting the population mean from an individual raw
score and then dividing the difference by the population standard deviation. In
normal distributions, results with a z-score of1.96 lie within the 95% prediction
interval, and z-scores of 2.58 lie within the 99% prediction interval.
Bovine primary rectal epithelial cell cultures. Bovine primary epithelial cells
were derived from lymphoid dense terminal rectum 0 to 5 cm proximal to
rectal-anal junction, as described previously (7, 30). Briefly, the mucosal scrap-
ings from terminal rectum of adult cattle from a local abattoir were digested in
DMEM (1% [vol/vol] fetal calf serum [FCS], 100 U of penicillin ml	1, 30 g of
streptomycin ml	1, and 25 g of gentamicin ml	1) containing 20 g of dispase
and 75 U of collagenase (Roche) ml	1, with gentle shaking at 37°C for 90 min to
release intact crypts. Crypts were enriched from contaminating gut microflora
and single cells, including fibroblasts using a series of differential centrifugation
steps with DMEM containing 2% sorbitol (30). Approximately 500 crypts were
seeded onto collagen (Vitrogen collagen; Nutacon, Netherlands)-coated four-
well chamber slides (Costar; Corning). The cells were grown to a stage of
confluence (approximately 3  105 cells per well, typically at 5 to 7 days after
initial primary epithelial cell culture). To inhibit the growth of fibroblasts, the
cells were cultured in MEM–D-valine (Servichem GmbH) containing 2.5% (vol/
vol) FCS, 0.25 U of insulin, 10 ng of epidermal growth factor ml	1, and 25 mg
of gentamicin ml	1 (23, 30, 46).
For the transcytosis studies, primary bovine terminal rectal epithelial cells
were allowed to establish monolayers on 3-m-pore-size polycarbonate filters of
35-mm transwell chambers (Corning Inc.) by growing them for 2 to 3 weeks until
they reached confluence. Before seeding primary bovine terminal rectal epithe-
lial cells, the transwell plates were coated with collagen (Nutagen) since it is
important to establish primary cell polarization. The collagen did not block the
pore, and this was checked in comparison to non-collagen-coated plates. The
integrity of the cell monolayer, polarization, and formation of tight junctions was
tested by measuring the TER using an epithelial voltmeter (WPI). Only filters of
cell monolayers that displayed the required TER (100 
/cm2) were used for the
bacterial transcytosis assay. Bacteria were prepared as described for the phago-
cytosis assays, and 100 l of bacterial suspension was added to each upper
chamber. Bacterial counts from the lower chamber were determined at 60 min
relative to the levels inoculated.
Characterization of bovine primary rectal cultured cells. The epithelial origin
of the cells was confirmed by immunostaining for cytokeratin intermediate fila-
ments. The cells at 5 days of culture were fixed with 2% PFA, permeabilized with
cold acetone for 5 min, washed with PBS, and stained with a pan-cytokeratin and
or anti-vimentin antibodies (Sigma, 1:300) for 3 h at 25°C. The cells were washed
with PBS, and the specific monoclonal antibodies were detected using fluorescein
isothiocyanate (FITC)- or TRITC (tetramethyl rhodamine isothiocyanate)-la-
beled secondary anti-rabbit or anti-mouse monoclonal antibody (Sigma) at 1:80.
The cell nuclei were stained with TO-PRO iodide (Molecular Probes). The
stained cells were mounted in fluorescence mounting medium Fluoromount
(Dako) and examined by using a Leica DMLB epifluorescence microscope. To
ascertain whether lymphoid cells were present in primary cell cultures from the
crypts isolated from lymphoid rich mucosal tissue, immunostaining was carried
out with a panel of seven monoclonal antibodies (Table 4) specific for different
immune cell types of cattle.
The percentages of cells expressing vimentin in the bovine terminal rectal
primary epithelial cell cultures were determined using flow cytometry. Briefly,
the trypsinized cells were fixed and permeabilized in 500 l of cell permeabili-
zation solution (BD Pharmingen) for 10 min at room temperature. The cells
were washed in PBS with 0.5% bovine serum albumin and 0.1% sodium azide.
The cells were incubated with primary anti-vimentin and the respective species-
specific isotype control antibodies, diluted in flow cytometry (FC) medium
(DMEM, 1% FBS, 0.1% sodium azide) at 4°C for 30 min, centrifuged (2,500 rpm
for 3 min), and washed twice in FC medium. The cells were then labeled with
FITC-labeled secondary antibodies at 4°C for 30 min, centrifuged again, and
washed twice in FC medium. The cell pellets were suspended in 200 l of FC
medium, and vimentin-expressing cells were quantified by using Calibur flow
cytometer (Becton Dickinson).
Uptake of inert microparticles and Salmonella enterica serovar Typhimurium
has been used as in vitro functional assay to ascertain M cells in cultures (14, 44).
Similar technique was adapted to identify M-cell subsets in bovine rectal epithe-
lial cell culture. Briefly, FITC-conjugated latex beads with a 0.2-m pore size
(Polysciences, Inc., Germany) were diluted (1:1,000) in DMEM containing 2%
FBS. Aliquots (100 l) of diluted beads were pipetted evenly onto 6-day-old
cultures, followed by incubation at 37°C for 45 min; the cells were then washed
three times in PBS and further incubated with Salmonella Typhimurium
(pUC18GFP-labeled SL1344 strain) (multiplicity of infection [MOI] of 1:100)
for 10 min. The cells were washed three times in PBS, fixed, and permeabilized
with 2% (wt/vol) PFA–0.25% (vol/vol) Triton X-100 at room temperature for 20
min. Staining of F-actin was carried out with Phalloidin-647 (diluted 1:40 in PBS;
Molecular Probes) for 45 min at room temperature. For colocalization studies
with vimentin, the cells were incubated overnight at 4°C with mouse anti-vimen-
tin monoclonal antibody (1:100; Sigma). This primary antibody was detected with
Alexa Fluor 594-tagged rabbit anti-mouse or goat anti-mouse polyclonal anti-
bodies according to the manufacturer’s instructions (Invitrogen). The cell nuclei
were stained with either TO-PRO iodide or DAPI (4,6-diamidino-2-phenylin-
dole; Merck) nuclear stains. The mounted slides were examined by confocal
microscopy. To examine the position of the beads, 0.4-m optical sections were
acquired and processed using the Imaris Surpuss module (Bitplane) computer
software program.
Coculture of Caco-2 cells with Raji-B cells and measurement of bacterial
translocation. Caco-2 cells were grown for 14 days in DMEM supplemented with
10% FBS, 15 mM L-glutamine, and 1% penicillin-streptomycin (Sigma) on trans-
well polycarbonate inserts (3-m pore size). This time allows the differentiation
and development of microvilli. These cells were then cocultured with 0.5  106
Raji-B cells in the basal compartment for 6 days (44). The TER was measured
every day before adding the Raji-B cells until it become consistent at 200 to 300

/cm2; however, it was not changed by coculture with Raji-B cells. Bacteria were
prepared as described for the phagocytosis assays, and 100 l of bacterial sus-
pension was added to each upper chamber. Bacterial counts from the lower
chamber were determined at 60 min relative to the levels inoculated.
Kanamycin protection assay to detect intracellular E. coli. Bacteria were
prepared as described for the phagocytosis assays. The bovine primary epithelial
cells were washed twice with MEM-HEPES without antibiotic for 1 h before the
bacterial culture reached an OD600 of 0.4, and the wells of confluent epithelial
monolayer were infected by using 100 l of bacterial suspension for each well.
The infected cells were incubated at 37°C with 5% CO2 and moisture for 1.5 h.
The bacterial suspension was removed, and the wells were washed four times
with PBS to remove the nonattached bacteria. A total of 500 l of MEM-HEPES
containing 750 g of kanamycin/ml was added to each well of the infected cells.
The infected cells were incubated for 3 h and then washed three times with PBS.
Then, 300 l of 0.1% Triton X-100 (in PBS) was added to each well to lyse the
cells. The bacteria were collected after scraping of the cells, serially diluted in
PBS, and triplicate plated onto LB plates with appropriate antibiotics. The
plates were incubated at 37°C for overnight, and the colonies were counted
the next day.
TABLE 4. Monoclonal antibodies used in immunocytochemical screening of bovine rectal primary epithelial cell cultures
Monoclonal antibody Specificity Cellular expression Sourcea Reference
CC21 CD21 Follicular dendritic cells, mature B cells IAH 57
CC20 Bovine CD1b Dendritic cells IAH 31
CC15 Bovine WC1 d T cell IAH 32
ILA-12 CD4 T helper cells ILRAD 78
ILA-51 CD8 Cytotoxic T cells ILRAD 78
ILA-156 CD40 B cells, antigen-presenting cells ILRAD 63
ILA-111 CD25 Activated T and B cells, macrophages ILRAD 12
ILA-43 CD2  T cells, natural killer cells ILRAD 78
Anti-hPH -Subunit of hPH Fibroblasts Acris GmbH 3
a ILRAD, International Laboratory for Research on Animal Diseases, Nairobi, Kenya; IAH, Institute for Animal Health, Compton, United Kingdom.
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Statistical design and analyses. All statistical analyses were carried out in R
(v2.10.1; R Foundation for Statistical Computing). All binding, uptake, and
translocation assays were repeated on at least separate occasions. For all anal-
yses, a similar methodology was adopted. Overall differences between strains
were first assessed, and if there were statistically significant differences, then post
hoc Tukey pairwise comparisons were carried out.
Three types of statistical models were used. Differences between strains in the
percentages of intracellular bacteria at either set time intervals, as determined by
fluorescence microscopy or as a measure of phagocytosis, were examined by
general linear models with binomial errors to account for the percentage nature
of the data. To ensure that any differences between experiments were accounted
for in the time interval analysis, which of the three experiments the data came
from was also entered as a covariate. When we considered differences in the
number of bacteria bound per microscopic slides between the three strains,
general linear models with Poisson errors were used to account for the integer
nature of the data.
For all other statistical analyses, analysis of covariance of the log10-trans-
formed number of bacteria posttranslocation was carried out to assess the dif-
ferences between strains. To adjust for differences in pretranslocation levels and
experiments, the number of bacteria pretranslocation and which of the three
experiments the translocation carried out were entered as covariates. Log trans-
formation was undertaken to normalize the residuals. Statistical significance was
taken when P was 0.05.
RESULTS
Strain-specific susceptibility to phagocytosis by cultured
macrophages. Previous research has demonstrated that EspF
is able to inhibit bacterial uptake into macrophages, although
the majority of the previous research examining this inhibition
has focused on the EspFO127 variant from EPEC O127 E2348/
69. Initially, EHEC O157, EHEC O26, and EPEC O127 were
compared for their capacity to inhibit their nonopsonized
phagocytosis into cultured macrophages. EPEC O127 bound in
significantly higher numbers to the macrophages (Fig. 1A, P 
0.001), and the majority remained external (Fig. 1B and C).
EHEC O26 exhibited an adherence level similar to that of
EHEC O157 but significantly less than that of EPEC O127
(Fig. 1A, P  0.001); however, it resisted uptake by macro-
phages in a way comparable to that of the EPEC strain (Fig. 1B
and C). In contrast, EHEC O157 adhered at lower levels, and
a significantly higher proportion was phagocytosed (Fig. 1B
and C). For example, at 90 min after addition 63%  3.3% of
EHEC O157 bacteria were internalized compared to only
33%  3.5% of EPEC O127 or 31%  6.3% of EHEC O26
(Fig. 1B). By 6 h after addition to the cultures, the macro-
phages lost their structural integrity in the presence of EPEC
O127. In contrast, macrophages exposed to EHEC were still
healthy at this time point, with relatively very few bacteria
evident (data not shown).
Strain-specific susceptibility to phagocytosis is associated
with espF allele expression. EHEC and EPEC serotypes ex-
press different variants of EspF (Fig. 2). EHEC O157 contains
four polyproline repeat regions (PRRs) compared to three in
EPEC O127 and EHEC O26. In addition, the three sequences
differ within the polyproline repeat regions and in the amino
terminus of the protein shown to be important for organelle
targeting (1, 17). To determine the relative contributions of the
different espF alleles in inhibiting phagocytosis, these were
amplified from E. coli O157, O127, and O26 and cloned into
pMB102 (Table 2) under the control of a pTAC promoter that
is inducible with IPTG. The sequences were confirmed to be
identical to those published in the National Center for Bio-
technology Information (NCBI) database for these serotypes,
FIG. 1. Comparison of EHEC O157, EHEC O26, and EPEC O127
interactions with RAW 264.7 macrophages. Confluent monolayers of
the mouse macrophages were infected with EPEC O127:H6 (E2348/
69), EHEC O26:H11 (ZAP1139), and EHEC O157:H7 (ZAP1163)
strains, and the number of bacteria inside (green) or outside (red) of
the macrophages was determined by fluorescence microscopy as de-
tailed in Materials and Methods. (A) Mean ( the 95% confidence
intervals) numbers of adherent bacteria per macrophage at 30 min
after addition of the bacteria at an MOI of 100. (B) Percentage ( the
95% confidence intervals) of intracellular bacteria at the time points
shown as determined by fluorescence microscopy for EHEC O157 (F),
EPEC O127 (}), and EPEC O26 (Œ). Significant differences of0.001
for O157 versus EPEC (), O157 versus O26 (), and EPEC
(xxx) versus EHEC O26 are indicated. (C) Confocal images were
acquired using a Zeiss Plan Apochromat 1.4 NA 63 oil immersion
lens and a multitrack (sequential scan) experimental set up on a Zeiss
LSM510. Scale bar, 10 m.
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resulting in the predicted amino acid sequences shown in Fig.
2. The clones were transformed into EPEC E2349/69espF
(Table 1), and the secretion profiles were examined. All strains
secreted comparable levels of the translocon protein EspD;
EspF secretion was detected from all three complemented
strains by Western blotting (Fig. 3B) but with potentially lower
levels detectable for the O26 variant. The complemented strains
were then compared in a macrophage phagocytosis assay at 90
min postinfection (Fig. 3A). All three alleles were able to
complement the espF knockout (Fig. 3, P  0.001), although
the espF gene from the E. coli serotype O157 (espFO157) allele
was significantly less effective at inhibiting uptake compared to
the espFO127 and espFO26 alleles (Fig. 3A, P  0.001). There
were no significant differences in the adherence levels for the
complemented strains (data not shown). These results indicate
that the capacity of the different strains to inhibit phagocytosis
correlates with the activity of the respective espF allele.
Strain-specific variation in M-cell translocation is associ-
ated with espF variation. Coculturing of human intestinal ep-
ithelial Caco-2 cells and Raji-B cells in vitro leads to the dif-
ferentiation of a subset of epithelial cells into antigen-sampling
cells (M cells) (44, 47). This in vitro “M-cell” culture system can
then be used to analyze bacterial translocation and the capacity
of bacteria to inhibit this trafficking (53). This trafficking is
presumed to occur by transcytosis, but this and other research
does not rule out the possibility of paracellular transport. Ev-
idence for M-cell translocation in the assay is provided by
comparison of translocation through a standard epithelial
Caco-2 monolayer which occurs at significantly lower levels
(Fig. 4A to C). To determine the contribution of espF to the
translocation of EHEC O157 through this M-cell culture sys-
tem, a defined deletion of espF was constructed in E. coli
O157:H7 TUV93-0 (Table 1). Translocation of the EHEC
O157 espF strain was significantly higher than that of the
wild-type strain across both the Caco-2/rajiB coculture and the
Caco-2 monolayer. The levels of translocation were restored to
those of the wild type by complementation with espFO157 in
trans (Fig. 4A).
The EHEC O157, EHEC O26, and EPEC O127 strains were
then compared in the same coculture translocation assay.
EHEC O157 demonstrated significantly higher levels of trans-
location compared to EPEC O127 and EHEC O26 (Fig. 4B,
P  0.001). To examine whether the espF alleles have an effect
on the level of translocation inhibition, EPEC E2349/69espF
transformed with the three amplified and cloned espF alleles
was analyzed in the same assay. All three complemented the
espF mutation in the EPECespF strain to a significant level
(Fig. 4C, P  0.001). As with the phagocytosis assay, the
espFO157 allele was the least effective of the three, being sig-
nificantly less effective than the espFO127 allele at inhibiting
translocation. This was the case for translocation across both
the Caco-2/Raji-B coculture and the Caco-2 monolayers, al-
though translocation through the coculture system always oc-
curred at significantly higher levels (P  0.001). Given the
FIG. 2. Alignment of EspF amino acid sequences from EHEC O157:H7 (EDL933); EPEC O127:H6 (E2348/69), and EHEC O26:H11
(ZAP1139). The proline-rich repeats (PRRs) are boxed with EHEC O157 containing an additional fourth repeat. Amino acid differences from the
EHEC O157 sequence are indicated in boldface. A binding site for SNX9 is highlighted in gray within the PRRs (1). The putative N-WASP binding
region is within the middle of the PRRs (1), although the most significant sequence diversity between these variants is at the ends of each PRR.
The leucine at position 16 (arrow) has been shown to be essential for EspF translocation into mitochondria, and this is changed to the similar
aliphatic amino acid isoleucine in EHEC O26 (58). Analysis of NCBI E. coli O157:H7 sequences showed no significant variation in the predicted
EspF amino acid sequence. The predicted EspF from an E. coli O26:H2 strain was identical to that shown for E. coli O26:H11 (data not shown).
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correlation with strain origin, these differences again indicate
variation in EspF activity between the different espF alleles.
The significance of espF alleles on the interaction of E. coli
with primary cultures of bovine rectal epithelial cells. Previous
work has established that EHEC O157:H7 colonizes the ter-
minal rectum of cattle, the main reservoir host (60). The tissue
at this site contains a high number of lymphoid follicles and
M-like cells that are present in the FAE (49). Primary cells
were cultured from a mixed population of crypts isolated from
this bovine terminal rectum (see Materials and Methods). The
cells in the monolayers expressed cytokeratins (Fig. 5A) indic-
ative of epithelial cells. Screening with a panel of antibodies
(Table 4) provided no indication of contaminating cells, such
as fibroblasts (data not shown). It was apparent that a small
proportion of cells expressed vimentin, an intermediate fila-
ment protein indicative of M cells (Fig. 5A and B). A subset of
vimentin-expressing cells endocytosed latex fluorescent micro-
particles (Fig. 5C and C1). S. enterica serovar Typhimurium
preferentially targets M cells in the gut (14) and therefore was
used to test whether the bacteria and the latex particles were
internalized by vimentin-expressing cells in culture. Indeed,
during early stages of infection, Salmonella Typhimurium in-
teracted primarily with vimentin-expressing cells in culture
(Fig. 5D) that also had internalized the latex beads (Fig. 5E),
a further indication that these cells can be considered M cells
based on previous M-cell characterization studies (44). Taken
together, these data indicate that primary cells cultured from
crypts isolated from bovine rectal FAE do contain a subset of
cells with characteristics of M cells and are capable of taking
up particles, including bacteria.
To determine the significance espF has on the interaction of
E. coli O157 with these primary cells, translocation across these
primary cell cultures was then assessed for the wild-type
strains, the EHEC O157 espF deletion, and EPEC espF
strain complemented with the three different alleles. In agree-
ment with the coculture translocation assay, espF significantly
contributed to inhibition of translocation through these cul-
tured cells (Fig. 6A); however, in clear contrast to the “human”
coculture system, EHEC O157 was significantly better in the
bovine assay at inhibiting translocation compared to EPEC
O127 and EHEC O26 (P 0.001) (Fig. 6B). In agreement with
this, the espFO157 allele showed the highest activity in restrict-
FIG. 3. Inhibition of phagocytosis (mean  the 95% confidence intervals) by different espF alleles. (A) A confluent monolayer of RAW 264.7
macrophages was infected with a panel of GFP-labeled espF EPEC strains transformed with espF cloned from EPEC O127:H6, EHEC O157:H7,
and EHEC O26:H11. The proportions of extracellular bacteria were determined at 90 min. The infected cells were fixed in 4% PFA. Bacteria were
stained with O-antigen-specific antibody detected with Alexa Fluor 594-conjugated secondary antibody. The intracellular versus total bacteria were
imaged and quantified as described in Materials and Methods. , P  0.001. (B) Levels of EspD and EspF secretion by EPEC O127 espF and
then complemented with the respective three espF alleles as indicated. Supernatants were prepared and separated in a standard sodium dodecyl
sulfate denaturing gel that was then stained with colloidal blue. The bottom panel shows the staining for the main EspD/B band. The middle panel
shows the same samples with detection for EspD. The top panel shows the detection of EspF. The supernatants were prepared from equal volumes
of bacteria (50 ml) cultured to an OD600 of 0.8. Experimental details are given in Materials and Methods.
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FIG. 4. Translocation of EPEC and EHEC strains across a Caco-2 and lympho-epithelial M-cell coculture system (black columns [A, C, and
E]) and Caco-2 cells only (white columns [B, D, and F]). (A and B) espF is required to inhibit EHEC O157 TUV93-0 translocation through M
cells. The translocation of EHEC O157 TUV93-0 was compared to an isogenic espF deletion mutant and complemented with espFO157 (pAT1,
Table 2). (C and D) Comparative translocation of EPEC O127:H6 strain E2348/69, EHEC O157:H7 ZAP198, and EHEC O26:H11 across the
coculture system. (E and F) Comparative translocation of an EPEC O127espF mutant complemented with the three defined espF alleles. , ,
and , statistical significances of P  0.05, P  0.01, and P  0.001, respectively.
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ing transcytosis in the EPEC espF background, although this
was not significant (Fig. 6C) compared to the two other alleles.
As an alternative assessment of the function of these alleles on
the bovine primary cells, an intracellular kanamycin protection
assay was developed that determined the intracellular bacterial
numbers at 90 min postinfection. The relative percentage of
bacteria taken up into cells is low but increased significantly
upon deletion of espF (Fig. 7A). EHEC O157 was taken up
into cells at significantly lower levels compared to EPEC O127
and EHEC O26 (Fig. 7B, P  0.001) in agreement with the
transcytosis results. This assay was then carried out with the
three espF alleles in the EPEC E2348/69espF strain. All three
espF alleles reduced uptake significantly (Fig. 7C, P  0.001)
with the espFO157 variant showing significantly higher activity
than the espFO127 (P  0.05) and espFO26 (P  0.001) alleles
(Fig. 6E).
The fact that the relative activities of the espF clones are
reversed in the bovine assays indicates that the differences
measured between the variants are not due to expression or
secretion levels. This is supported by the correlations with the
relative activity levels of the parental strains in the different
assays. Taken together, it is likely that the relative activities are
due to different functional capacities of the EspF variants and,
in turn, these are dependent on the host cell type in which the
variants are acting.
Molecular basis to the comparative activity of EHEC and
EPEC espF alleles. Previous work has established that EspF
has a number of interacting partners in eukaryotic cells includ-
ing interactions with both sorting nexin 9 (SNX9) and N-
WASP. Since SNX9 is important for endocytosis dynamics and
N-WASP is central to actin polymerization, we investigated by
LUMIER binding assay whether differences in the interactions
of the EspF variants with these proteins could account for the
differences in functional levels measured in the present study.
To quantify the binding activity, the three EspF variants, as
well as their binding partners SNX9 (human) and N-WASP
(human), were cloned into plasmids that express either protein
A-tagged proteins or Renilla luciferase fusion proteins as de-
scribed in Materials and Methods. Cell lysates containing both
sets of tagged proteins were generated, and then the protein
A-tagged complexes were removed by using antibody-coated
beads. Total fluorescence and captured fluorescence were
measured and normalized, and z-scores for each interaction
were determined as outlined in Materials and Methods and as
previously published (4). The results confirmed the interaction
of all of the EspF variants with both SNX9 and N-WASP (Fig.
8). The EspFO157 had the lowest interaction score of the three
variants with luciferase-linked SNX9 and also had the lowest
interaction score of the three with respect to binding to N-
WASP.
DISCUSSION
EPEC is known to inhibit phagocytosis via inhibition of
PI3K activity, and this has been shown to be due to the activity
of the type III-secreted effector EspF (11, 70). Although more
recent research has established that a number of secreted pro-
teins can also function to inhibit uptake into cells, including
EspB (34), EspJ (52), and EspH (18). The inhibition of EPEC
translocation through M cells has been shown to be dependent
FIG. 5. Characterization of bovine primary rectal epithelial cells.
(A) Heterogeneous population of epithelial cells in a primary cell
culture from the bovine terminal rectum. A 5-day-old culture was
prepared and immunolabeled to detect vimentin (green), pan-cytok-
eratins (red), and nuclei (blue) as described in Materials and Methods.
A subset of the cells expressed the intermediate filament protein,
vimentin (green), which is indicative of M cells. (B) Vimentin-express-
ing cells were quantified by using flow cytometry from four indepen-
dent primary cultures (standard deviation, 0.3). (C) Microparticle
colocalization with vimentin-expressing cells. A subset of vimentin
expressing (red) cells interacted with fluorescent microparticles
(green). Panel C1 shows the inset image in panel C digitally magnified
by a factor of 4. The primary rectal epithelial cells were incubated with
latex particles (green, 0.2 m in size) at 37°C and 5% CO2 for 45 min,
fixed, permeabilized, and labeled with anti-vimentin (red) and
TO-PRO nuclear stain (blue). (D) Orthogonal section demonstrating
S. enterica serovar Typhimurium uptake by vimentin-expressing cells
during the early stages of interaction. The cells were infected with
mid-log-phase S. Typhimurium (pUC18GFP-labeled SL1344 strain) at
an MOI of 1:100 at 37°C and 5% CO2 for 10 min. (E) Orthogonal
section demonstrating the combined uptake of S. Typhimurium (white
arrow, DAPI stained) and microparticles (yellow arrow, green) by
vimentin-positive cells (red) in a bovine rectal primary culture. The
cells were incubated with latex particles (green) for 45 min, washed
(3 PBS), and further infected with mid-log-phase S. Typhimurium at
an MOI of 1:100 for 10 min. The infected cells were fixed and labeled
with anti-vimentin (red) and DAPI nuclear stain. Confocal images
were acquired by using a Zeiss LSM510 with a 63 objective lens).
Scale bar, 10 m.
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on espF, presumably in a manner analogous to its activity on
macrophages. Comparison of EspF protein sequences from
EPEC O127, EHEC O26, and EHEC O157 shows a number of
differences in both the localization domain and in the number
and sequence of proline-rich repeats (PRRs). The aim of the
present study was to investigate whether these differences af-
fected the capacity of the EspF variants to (i) inhibit bacterial
phagocytosis into macrophages, (ii) inhibit M-cell transloca-
tion in a human-derived Caco-2/Raji-B coculture system, and
(iii) inhibit uptake into bovine primary epithelium, containing
FIG. 6. Interaction of EHEC and EPEC strain with cultured epithelial cells from the bovine terminal rectum. (A) espF limits EHEC O157
TUV93-0 uptake into rectal primary cells. The transcytosis levels (%) of EHEC O157 TUV93-0 were compared to an isogenic espF deletion mutant
and complemented with espFO157 (pAT1, Table 2).(B) Comparative transcytosis levels (%) of wild-type strains EPEC O127:H6 E2348/69, EHEC
O157:H7 TUV93-0, and EHEC O26:H11 on interaction with bovine rectal primary cells. (C) Comparative transcytosis levels (%) of an EPEC
O127espF mutant complemented with the three defined espF alleles.  and , statistical significances of P  0.05 and P  0.001, respectively.
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M-like cells, cultured from the terminal rectum of cattle, the
predominant colonization site of EHEC O157:H7 in cattle.
Strain comparisons demonstrated that both EPEC O127
E2348/69 and E. coli O26:H11 had a much greater capacity to
block nonopsonized phagocytosis into cultured murine macro-
phages compared to EHEC O157:H7. Both the EHEC O157
and the EHEC O26 strains adhered to the macrophages at
lower levels than the EPEC O127 strain (Fig. 1). To determine
whether this strain difference could be accounted for by vari-
ation in the EspF effector protein, the genes from the three
FIG. 7. Interaction of EHEC and EPEC strain with cultured epithelial cells from the bovine terminal rectum. (A) espF limits EHEC O157
TUV93-0 uptake into rectal primary cells. The intracellular levels of EHEC O157 TUV93-0 were compared to an isogenic espF deletion mutant
and complemented with espFO157 (pAT1, Table 2). (B) Comparative intracellular levels of wild-type strains EPEC O127:H6 E2348/69, EHEC
O157:H7 TUV93-0, and EHEC O26:H11 on interaction with bovine rectal primary cells. (C) Comparative intracellular levels of an EPEC
O127espF mutant complemented with the three defined espF alleles.  and , statistical significances of P  0.05 and P  0.001, respectively.
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serogroups, EPEC O127, EHEC O157, and EHEC O26 were
cloned and expressed in EPEC O127 from which espF had
been deleted. Although the espF alleles from both O127 and
O26 completely complemented the mutant, the espFO157 allele
showed a significantly reduced ability to block phagocytosis.
This indicates that the initial strain observations may be ac-
counted for by differences in the espF alleles. This result does
not rule out important antiphagocytic functions for the other
effector proteins but does indicate synergistic roles with EspF
and a significant dependence on EspF. The different alleles did
not alter the level of attachment of the complemented EPEC
strain to Caco-2 cells, a finding in line with previous research
indicating that EspF has no direct role in attachment and
attaching/effacing lesion formation (55, 61, 74).
It was then investigated whether the different espF alleles
varied in their capacity to inhibit E. coli translocation through
M cells. The rationale for investigating this function is the
finding that EHEC O157:H7 predominantly colonizes the ter-
minal rectum of its main reservoir host, cattle, and that this site
is rich in lymphoid follicles (60). Epithelium associated with
lymphoid follicles is subject to different signals from the high
abundance of B and T cells in these follicles leading to pro-
duction of M cells (44) that sample lumen particles from the
gut, delivering them to antigen-presenting cells that initiate
appropriate adaptive immune responses at these sites. M cells
have been postulated to be an important cell for the initial
uptake or colonization by different enteric bacterial pathogens
such as Salmonella, Shigella, and E. coli (37, 45). For EHEC
O157:H7, it is a cell type that the bacteria will encounter when
colonizing the terminal rectum (49, 60) and, consequently,
inhibiting translocation may promote colonization, for exam-
ple, by providing an initial attachment site and/or limiting
bacterial presentation to the host’s immune system. The origin
of M cells is unclear since studies either support their deriva-
tion from enterocytes via extrinsic stimuli (luminal antigens
and/or lymphoid-follicle derived signals) or conclude that they
originate from lineage-specific precursor cells (25, 72, 73, 75).
An M-cell coculture system was first defined in 1997 (44) and
makes use of the capacity of Raji-B cells to signal differentia-
tion of human colon-derived Caco-2 cells. Initial experiments
demonstrated that espF from EHEC O157 is required to limit
EHEC O157 translocation through M cells but that the EHEC
O157 espF allele was again reduced in its capacity to limit
translocation of E. coli compared to the O127 and O26 alleles.
This finding mirrored the relative capacity of the specific
strains to inhibit their translocation, again demonstrating the
significance of the espF allele for the strain phenotype.
The strains and espF alleles were then compared on primary
cells cultured from crypts isolated from the bovine terminal
rectum. These cultures were further characterized in the pres-
ent study. A subset of the primary cells expressed the interme-
diate filament protein, vimentin, that is found in rabbit intes-
tinal M cells (13). M cells in the terminal rectum of cattle have
been demonstrated to express vimentin as the predominant
intermediate filament protein (49), and the same staining was
apparent in the cultured primary cells. A subset of vimentin-
expressing cells was also able to take up S. Typhimurium (Fig.
5D) alone and S. Typhimurium and beads together (Fig. 5E).
Therefore, the bovine rectal primary cultures contain a subset
of cells that express vimentin and have characteristics of M
cells. There was a significant role for espF in inhibiting bacte-
rial uptake into cells, and translocation through these cells and
the activity of the strains correlated with that of the espF
alleles. An important result was that, in contrast to the previ-
ous experiments on mouse macrophages and the human-de-
rived M-cell coculture system, EHEC O157 was the most ef-
fective strain at inhibiting uptake and translocation and this
correlated with the relative activity of the espF alleles (Fig. 6).
Taken together, these results indicate that EHEC O157 and
the espFO157 allele are more effective at inhibiting uptake into
bovine M cells than the O26 and O127 strains and alleles, a
reversal of the situation observed for the interactions with
murine macrophages and the human coculture system.
There are multiple phenotypes associated with EspF in ad-
dition to inhibition of phagocytosis, including inhibition of
water transport and disruption of tight junctions mitochondria
and the nucleolus (17, 29, 58, 80). Uptake functions are likely
to be related to EspF interactions with N-WASP and SNX9
(1). N-WASP stimulates actin filament assembly by direct ac-
tivation of the Arp2/3 complex, and SNX9 is essential for
clathrin-coated pits (CCPs) at the late stages of vesicle forma-
tion. SNX9 binds to 2 appendages of adaptor protein com-
plex 2 (AP-2) and interacts with clathrin and dynamin-2, two
other important molecules in the endocytic process (48, 77).
SNX9 has two lipid interaction domains; a phospholipid-bind-
FIG. 8. Comparative binding analysis between EspF variants and
human SNX9 or N-WASP. In the LUMIER binding assay, the espF
alleles were expressed with a protein A tag and then immobilized on
immunoglobulin beads. The interaction between proto-oncogenes, c-
Fos and c-Jun, was used as a positive control. SNX9 and N-WASP
were expressed with Renilla luciferase tags and incubated with the
immobilized EspF variants. The luminescence signals were determined
and normalized against negative controls, and z-scores were calculated
as described previously (4, 9) and in Materials and Methods.
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ing region termed the phox (PX) domain, followed by a puta-
tive Bin/amphiphysin/Rvs (BAR) lipid-binding domain. The
BAR domain is a banana-shaped helical dimer that senses
membrane curvature and can reconfigure lipid vesicles or
sheets into membrane tubules (1). SNX9 also possesses an
N-terminal Src homology-3 (SH3) protein interaction region
that was recently shown to bind WASP (2) and to functionally
activate dynamin at CCPs. Therefore, SNX9 is an important
factor in remodeling the membrane and cytoskeletal during
endocytosis (1, 77). The SH3 domain of SNX9 binds to the
PPRs of EspF (1, 17). Despite both direct and indirect (via
SNX9) activation of N-WASP, EspF is not considered to have
a role in A/E lesion formation (54, 55). To determine whether
the different EspF variants have different affinities for SNX9
and N-WASP, the interactions were assayed inside trans-
fected HEK293 cells using a LUMIER assay (4; described in
Materials and Methods). This in-cell assay confirmed that
all three EspF variants bound to both N-WASP and SNX9,
although EspFO157 showed a lower interaction score with both
SNX9 and N-WASP compared to the other two variants.
Whether this is due to a reduced affinity of EspFO157 for these
two proteins remains to be determined. A specific region in the
PRRs of EspF (shaded gray in Fig. 2) interacts directly with
SNX9 through its SH3 domain-binding motif. There are only
minor differences in this region between the serotypes exam-
ined here, and we cannot determine whether these or their
presentation, due to sequence changes in flanking regions,
account for the differences observed.
The published Bos taurus sequence for SNX9 (NCBI) con-
tains a number of changes over the human variant used in the
LUMIER assays; however, these differences are mainly pres-
ent in the amino terminus of the predicted bovine SNX9 and
lie outside the SH3 domain. There are also very few sequence
differences between the predicted Bos taurus N-WASP protein
sequence (NCBI) and the human variant. Taken together, our
results indicate that there are likely to be other protein inter-
actions involving EspF that could also contribute to the host
specificity demonstrated here. The greatest region of diversity
between the variants lies in the motifs preceding the second
and third PRRs (amino acids 110 to 118 and amino acids 157
to 165 in Fig. 2), with no established function for these regions.
Future work will seek to identify other interacting partners for
EspF and address how important M-cell interactions are for
colonization of cattle at the terminal rectum or whether other
factors may explain the tropism of the EHEC O157:H7 for this
gastrointestinal site.
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